Perioperative medicine & outcomes

Psychometric evaluation of the modified quality of recovery score for the postanaesthesia care unit (QoR-PACU2)—A prospective validation study

Anaesth Crit Care Pain MedPublished Prospective validation study

Authors' conclusion

The QoR-PACU2 assesses self-reported QoR after surgery in the PACU. Measures of feasibility, validity, and reliability were consistently high. Measures of responsiveness were moderate, which might be attributable to the heterogeneity of the study population.

Study context

Population
Adults scheduled for non-cardiac surgery with GAincluded in final analysis
Participants
307 adults
Outcome
Psychometric properties of QoR-PACU2
Methodological detailsQoR-PACU2 administered before surgery and in post-anesthesia care unit (PACU) at the time of the decision to discharge
  • QoR-PACU2 administered before surgery and in PACU at the time of the decision to discharge

Performance

As reported in the abstract

Cronbach's alpha
0.70 (95% CI 0.66-0.75)
Intra-class correlation coefficient, intra-rater reliability
0.86 (n = 24; 95% CI 0.70-0.94, p < 0.001)
Intra-class correlation coefficient, inter-rater reliability
0.94 (n = 31; 95% CI 0.90 to 0.97, p < 0.001)
Cohen's effect size
0.68
Standardized response mean
0.57

Further findings

Construct validity of postoperative QoR-PACU2 sum scores

Scores differed across categories of sex, perioperative and surgical risk, and modes of airway management
Duration of anaesthesia and surgery, maximum pain intensity and analgesic requirement in PACU, and PACU LOS inversely correlated with quality of recovery (QoR) in PACU

Original publication

Psychometric evaluation of the modified quality of recovery score for the postanaesthesia care unit (QoR-PACU2)—A prospective validation study. Anaesth Crit Care Pain Med. Published 16 March 2024. doi:10.1016/j.accpm.2024.101380

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.